Chemotherapy: Electromotive mitomycin in superficial bladder cancer

Nature Reviews Clinical Oncology

Volumn 8, Issue 11, 2011, Pages 633-634

  Oosterlinck, Willem ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; MITOMYCIN;

ARTICLE; BALLOON CATHETER; BLADDER CANCER; BLADDER MUCOSA; BLADDER WALL; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; DISEASE FREE INTERVAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG PENETRATION; ELECTRIC FIELD; ELECTROOSMOSIS; HUMAN; HYPERTHERMIC THERAPY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PULSE GENERATOR; RECURRENCE RISK; SUPERFICIAL BLADDER CANCER; TRANSURETHRAL RESECTION;

ADMINISTRATION, INTRAVESICAL; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, TRANSITIONAL CELL; ELECTROCHEMOTHERAPY; HUMANS; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 80155150297     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2011.140     Document Type: Article

References (9)

1. Kalsi, J., Harland, S. J. & Feneley, M. R. Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma. Expert Opin. Drug. Deliv. 5, 137-45 (2008). (Pubitemid 351234114)
2. Brausi, M. et al. Intravesical electromotive administration of drugs for treatment of superficial bladder cancer: a comparative Phase II study. Urology 51, 506-509 (1998). (Pubitemid 28136698)
3. Riedl, C. R., Knoll, M., Plas, E. & Pflüger, H. Intravesical electromotive drug administration technique: preliminary results and side effects. J. Urol. 159, 1851-1856 (1998). (Pubitemid 29190711)
4. Di Stasi, S. M. et al. Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: a prospective randomized study. J. Urol. 170, 777-782 (2003). (Pubitemid 36999554)
5. Di Stasi, S. M. et al. Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial. Lancet Oncol. 7, 43-51 (2006). (Pubitemid 43025392)
6. Di Stasi, S. M. et al. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial. Lancet Oncol. 12, 871-879 (2011).
7. Babjuk, M. et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur. Urol. 997-1008 (2011).
8. Sylvester, R. J, Oosterlinck,W. & van der Meijden, A. P. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J. Urol. 171, 2186-2190 (2004). (Pubitemid 38625431)
9. Lammers, R. J. et al. The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review. Eur. Urol. 60, 81-93 (2011).